INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Replimune Group, Inc. of Class Action Lawsuit and Upcoming Deadlines – REPL
I'm PortAI, I can summarize articles.
Pomerantz Law Firm has filed a class action lawsuit against Replimune Group, Inc. (NASDAQ: REPL) for alleged securities fraud. Investors who suffered losses are encouraged to contact the firm by September 22, 2025, to be appointed as Lead Plaintiff. The lawsuit follows a significant stock price drop after the FDA issued a Complete Response Letter regarding Replimune's Biologics License Application for RP1, leading to a 77.24% decline in stock value on July 22, 2025.
Source: MorningStar The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments